Dr. Emil Lou and Emma Weston-Dimery Honored on 2026 TIME100 Health List for Cancer Research Breakthroughs Dr. Emil Lou of Intima Bioscience and patient Emma Weston-Dimery receive recognition on the 2026 TIME100 Health list for their contributions to cancer research.

Dr. Emil Lou and Emma Weston-Dimery Honored on 2026 TIME100 Health List for Cancer Research Breakthroughs #United_States #Minneapolis #Intima_Bioscience #Emil_Lou #CISH

Inside a lifesaving 'last resort' clinical trial—have we finally solved the problem of chemo-resistant colon cancer? | MDLinx When Emma Dimery, 35, was told her stage IV colon cancer was terminal, she’d exhausted nearly every standard treatment option—surgery, multiple rounds of chemotherapy, radiation, and immunotherapy. No...

Coverage from MDLinx about our recently presented and published #immunotherapy #clinicaltrial targeting the intracellular checkpoint #CISH - completed at the Masonic Cancer Center, University of Minnesota:
www.mdlinx.com/article/insi...

SciTech Chronicles. . . . . . . . .May 3rd, 2025 From the lab to the street,trust in science not deceit.. Vol II No 27 339 links Curated Mission Control RSS Feed Vol II No. 2 Wordpress ...

SciTech Chronicles. . . . . . . . .May 3rd, 2025

bit.ly/stc050325

#LEVA #multi-terrain #"Euro-type cargo" #RIVR #"Cosmic inflation" #"102 Infrared Colors" #astrophysics #exposure #Kuiper #infrared #arXiv #"Solar System's Plane" #CRISPR/Cas9 #stage IV" #CISH #TILS #microelectromechanical #DSP #39cc

Targeting Novel Immune Checkpoint Shows Promise in Metastatic CRC Patient with disease refractory to multiple lines of therapy had a response lasting over 2 years

Targeting Novel Immune Checkpoint Shows Promise in Metastatic CRC - article by Mike Bassett @medpagetoday.bsky.social on the #CRISPR edited #CISH KO #celltherapy trial I presented earlier this week at #AACR25 and published @thelancetoncol.bsky.social www.medpagetoday.com/meetingcover...

Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Cancer Presented at 2025 American Association for Cancer Research (AACR) Annual Meeting /PRNewswire/ -- Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancers, presented data from a first-in-human...

#PressRelease via
@prnewswire.bsky.social on Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Colorectal Cancer - trial results I presented April 29 at @theaacr.bsky.social
#AACR25 prn.to/44BYJaz #crcsm #CRISPR #coloncancer #CISH

I will be presenting the final results from this #clinicaltrial next Tuesday April 29 at #AACR25:
abstractsonline.com/pp8/#!/20273...

#CRISPR #CISH #immunotherapy #immunooncology #cancerresearch #clinicaltrial #coloncancer #rectalcancer #colorectalcancer

@theaacr.bsky.social